Global Hereditary Angioedema Treatment Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Hereditary Angioedema Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Hereditary Angioedema Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hereditary Angioedema Treatment market. Hereditary Angioedema Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hereditary Angioedema Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hereditary Angioedema Treatment market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Hereditary Angioedema Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hereditary Angioedema Treatment market. It may include historical data, market segmentation by Type (e.g., C1 Estearse Inhibitors (Plasma Products, Recombinant Products), Selective Bradykinin B2 Receptor Antagonists (Firazyr)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hereditary Angioedema Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hereditary Angioedema Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hereditary Angioedema Treatment industry. This include advancements in Hereditary Angioedema Treatment technology, Hereditary Angioedema Treatment new entrants, Hereditary Angioedema Treatment new investment, and other innovations that are shaping the future of Hereditary Angioedema Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hereditary Angioedema Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Hereditary Angioedema Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hereditary Angioedema Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hereditary Angioedema Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hereditary Angioedema Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hereditary Angioedema Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hereditary Angioedema Treatment market.
Market Segmentation:
Hereditary Angioedema Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Hereditary Angioedema Treatment market?
What factors are driving Hereditary Angioedema Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hereditary Angioedema Treatment market opportunities vary by end market size?
How does Hereditary Angioedema Treatment break out type, application?
According to our LPI (LP Information) latest study, the global Hereditary Angioedema Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Hereditary Angioedema Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hereditary Angioedema Treatment market. Hereditary Angioedema Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hereditary Angioedema Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hereditary Angioedema Treatment market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Hereditary Angioedema Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hereditary Angioedema Treatment market. It may include historical data, market segmentation by Type (e.g., C1 Estearse Inhibitors (Plasma Products, Recombinant Products), Selective Bradykinin B2 Receptor Antagonists (Firazyr)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hereditary Angioedema Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hereditary Angioedema Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hereditary Angioedema Treatment industry. This include advancements in Hereditary Angioedema Treatment technology, Hereditary Angioedema Treatment new entrants, Hereditary Angioedema Treatment new investment, and other innovations that are shaping the future of Hereditary Angioedema Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hereditary Angioedema Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Hereditary Angioedema Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hereditary Angioedema Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hereditary Angioedema Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hereditary Angioedema Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hereditary Angioedema Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hereditary Angioedema Treatment market.
Market Segmentation:
Hereditary Angioedema Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
- Selective Bradykinin B2 Receptor Antagonists (Firazyr)
- Kallikrein Inhibitors (Kalbitor, Takhzyro)
- Others (Conventional Drugs, Pipeline Drugs)
- Hospital Pharmacies
- Retail Pharmacies
- Others (online pharmacies, mail pharmacies)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL
- Pharming Group
- Shire plc (Takeda Pharmaceutical Company Limited)
- Ionis Pharmaceuticals
- Attune Pharmaceuticals
- BioCryst Pharmaceuticals
- KalVista Pharmaceuticals
What is the 10-year outlook for the global Hereditary Angioedema Treatment market?
What factors are driving Hereditary Angioedema Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hereditary Angioedema Treatment market opportunities vary by end market size?
How does Hereditary Angioedema Treatment break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hereditary Angioedema Treatment Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Hereditary Angioedema Treatment by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Hereditary Angioedema Treatment by Country/Region, 2019, 2023 & 2030
2.2 Hereditary Angioedema Treatment Segment by Type
2.2.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
2.2.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
2.2.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
2.2.4 Others (Conventional Drugs, Pipeline Drugs)
2.3 Hereditary Angioedema Treatment Sales by Type
2.3.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
2.3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2019-2024)
2.3.3 Global Hereditary Angioedema Treatment Sale Price by Type (2019-2024)
2.4 Hereditary Angioedema Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Others (online pharmacies, mail pharmacies)
2.5 Hereditary Angioedema Treatment Sales by Application
2.5.1 Global Hereditary Angioedema Treatment Sale Market Share by Application (2019-2024)
2.5.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Application (2019-2024)
2.5.3 Global Hereditary Angioedema Treatment Sale Price by Application (2019-2024)
3 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT BY COMPANY
3.1 Global Hereditary Angioedema Treatment Breakdown Data by Company
3.1.1 Global Hereditary Angioedema Treatment Annual Sales by Company (2019-2024)
3.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Company (2019-2024)
3.2 Global Hereditary Angioedema Treatment Annual Revenue by Company (2019-2024)
3.2.1 Global Hereditary Angioedema Treatment Revenue by Company (2019-2024)
3.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Company (2019-2024)
3.3 Global Hereditary Angioedema Treatment Sale Price by Company
3.4 Key Manufacturers Hereditary Angioedema Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hereditary Angioedema Treatment Product Location Distribution
3.4.2 Players Hereditary Angioedema Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEREDITARY ANGIOEDEMA TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Hereditary Angioedema Treatment Market Size by Geographic Region (2019-2024)
4.1.1 Global Hereditary Angioedema Treatment Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Hereditary Angioedema Treatment Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Hereditary Angioedema Treatment Market Size by Country/Region (2019-2024)
4.2.1 Global Hereditary Angioedema Treatment Annual Sales by Country/Region (2019-2024)
4.2.2 Global Hereditary Angioedema Treatment Annual Revenue by Country/Region (2019-2024)
4.3 Americas Hereditary Angioedema Treatment Sales Growth
4.4 APAC Hereditary Angioedema Treatment Sales Growth
4.5 Europe Hereditary Angioedema Treatment Sales Growth
4.6 Middle East & Africa Hereditary Angioedema Treatment Sales Growth
5 AMERICAS
5.1 Americas Hereditary Angioedema Treatment Sales by Country
5.1.1 Americas Hereditary Angioedema Treatment Sales by Country (2019-2024)
5.1.2 Americas Hereditary Angioedema Treatment Revenue by Country (2019-2024)
5.2 Americas Hereditary Angioedema Treatment Sales by Type
5.3 Americas Hereditary Angioedema Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Angioedema Treatment Sales by Region
6.1.1 APAC Hereditary Angioedema Treatment Sales by Region (2019-2024)
6.1.2 APAC Hereditary Angioedema Treatment Revenue by Region (2019-2024)
6.2 APAC Hereditary Angioedema Treatment Sales by Type
6.3 APAC Hereditary Angioedema Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hereditary Angioedema Treatment by Country
7.1.1 Europe Hereditary Angioedema Treatment Sales by Country (2019-2024)
7.1.2 Europe Hereditary Angioedema Treatment Revenue by Country (2019-2024)
7.2 Europe Hereditary Angioedema Treatment Sales by Type
7.3 Europe Hereditary Angioedema Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hereditary Angioedema Treatment by Country
8.1.1 Middle East & Africa Hereditary Angioedema Treatment Sales by Country (2019-2024)
8.1.2 Middle East & Africa Hereditary Angioedema Treatment Revenue by Country (2019-2024)
8.2 Middle East & Africa Hereditary Angioedema Treatment Sales by Type
8.3 Middle East & Africa Hereditary Angioedema Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Treatment
10.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
10.4 Industry Chain Structure of Hereditary Angioedema Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hereditary Angioedema Treatment Distributors
11.3 Hereditary Angioedema Treatment Customer
12 WORLD FORECAST REVIEW FOR HEREDITARY ANGIOEDEMA TREATMENT BY GEOGRAPHIC REGION
12.1 Global Hereditary Angioedema Treatment Market Size Forecast by Region
12.1.1 Global Hereditary Angioedema Treatment Forecast by Region (2025-2030)
12.1.2 Global Hereditary Angioedema Treatment Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hereditary Angioedema Treatment Forecast by Type
12.7 Global Hereditary Angioedema Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Hereditary Angioedema Treatment Product Portfolios and Specifications
13.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 Pharming Group
13.2.1 Pharming Group Company Information
13.2.2 Pharming Group Hereditary Angioedema Treatment Product Portfolios and Specifications
13.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pharming Group Main Business Overview
13.2.5 Pharming Group Latest Developments
13.3 Shire plc (Takeda Pharmaceutical Company Limited)
13.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Company Information
13.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Portfolios and Specifications
13.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Main Business Overview
13.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Latest Developments
13.4 Ionis Pharmaceuticals
13.4.1 Ionis Pharmaceuticals Company Information
13.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ionis Pharmaceuticals Main Business Overview
13.4.5 Ionis Pharmaceuticals Latest Developments
13.5 Attune Pharmaceuticals
13.5.1 Attune Pharmaceuticals Company Information
13.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Attune Pharmaceuticals Main Business Overview
13.5.5 Attune Pharmaceuticals Latest Developments
13.6 BioCryst Pharmaceuticals
13.6.1 BioCryst Pharmaceuticals Company Information
13.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BioCryst Pharmaceuticals Main Business Overview
13.6.5 BioCryst Pharmaceuticals Latest Developments
13.7 KalVista Pharmaceuticals
13.7.1 KalVista Pharmaceuticals Company Information
13.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 KalVista Pharmaceuticals Main Business Overview
13.7.5 KalVista Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hereditary Angioedema Treatment Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Hereditary Angioedema Treatment by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Hereditary Angioedema Treatment by Country/Region, 2019, 2023 & 2030
2.2 Hereditary Angioedema Treatment Segment by Type
2.2.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
2.2.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
2.2.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
2.2.4 Others (Conventional Drugs, Pipeline Drugs)
2.3 Hereditary Angioedema Treatment Sales by Type
2.3.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
2.3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2019-2024)
2.3.3 Global Hereditary Angioedema Treatment Sale Price by Type (2019-2024)
2.4 Hereditary Angioedema Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Others (online pharmacies, mail pharmacies)
2.5 Hereditary Angioedema Treatment Sales by Application
2.5.1 Global Hereditary Angioedema Treatment Sale Market Share by Application (2019-2024)
2.5.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Application (2019-2024)
2.5.3 Global Hereditary Angioedema Treatment Sale Price by Application (2019-2024)
3 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT BY COMPANY
3.1 Global Hereditary Angioedema Treatment Breakdown Data by Company
3.1.1 Global Hereditary Angioedema Treatment Annual Sales by Company (2019-2024)
3.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Company (2019-2024)
3.2 Global Hereditary Angioedema Treatment Annual Revenue by Company (2019-2024)
3.2.1 Global Hereditary Angioedema Treatment Revenue by Company (2019-2024)
3.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Company (2019-2024)
3.3 Global Hereditary Angioedema Treatment Sale Price by Company
3.4 Key Manufacturers Hereditary Angioedema Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hereditary Angioedema Treatment Product Location Distribution
3.4.2 Players Hereditary Angioedema Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEREDITARY ANGIOEDEMA TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Hereditary Angioedema Treatment Market Size by Geographic Region (2019-2024)
4.1.1 Global Hereditary Angioedema Treatment Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Hereditary Angioedema Treatment Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Hereditary Angioedema Treatment Market Size by Country/Region (2019-2024)
4.2.1 Global Hereditary Angioedema Treatment Annual Sales by Country/Region (2019-2024)
4.2.2 Global Hereditary Angioedema Treatment Annual Revenue by Country/Region (2019-2024)
4.3 Americas Hereditary Angioedema Treatment Sales Growth
4.4 APAC Hereditary Angioedema Treatment Sales Growth
4.5 Europe Hereditary Angioedema Treatment Sales Growth
4.6 Middle East & Africa Hereditary Angioedema Treatment Sales Growth
5 AMERICAS
5.1 Americas Hereditary Angioedema Treatment Sales by Country
5.1.1 Americas Hereditary Angioedema Treatment Sales by Country (2019-2024)
5.1.2 Americas Hereditary Angioedema Treatment Revenue by Country (2019-2024)
5.2 Americas Hereditary Angioedema Treatment Sales by Type
5.3 Americas Hereditary Angioedema Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Angioedema Treatment Sales by Region
6.1.1 APAC Hereditary Angioedema Treatment Sales by Region (2019-2024)
6.1.2 APAC Hereditary Angioedema Treatment Revenue by Region (2019-2024)
6.2 APAC Hereditary Angioedema Treatment Sales by Type
6.3 APAC Hereditary Angioedema Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hereditary Angioedema Treatment by Country
7.1.1 Europe Hereditary Angioedema Treatment Sales by Country (2019-2024)
7.1.2 Europe Hereditary Angioedema Treatment Revenue by Country (2019-2024)
7.2 Europe Hereditary Angioedema Treatment Sales by Type
7.3 Europe Hereditary Angioedema Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hereditary Angioedema Treatment by Country
8.1.1 Middle East & Africa Hereditary Angioedema Treatment Sales by Country (2019-2024)
8.1.2 Middle East & Africa Hereditary Angioedema Treatment Revenue by Country (2019-2024)
8.2 Middle East & Africa Hereditary Angioedema Treatment Sales by Type
8.3 Middle East & Africa Hereditary Angioedema Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Treatment
10.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
10.4 Industry Chain Structure of Hereditary Angioedema Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hereditary Angioedema Treatment Distributors
11.3 Hereditary Angioedema Treatment Customer
12 WORLD FORECAST REVIEW FOR HEREDITARY ANGIOEDEMA TREATMENT BY GEOGRAPHIC REGION
12.1 Global Hereditary Angioedema Treatment Market Size Forecast by Region
12.1.1 Global Hereditary Angioedema Treatment Forecast by Region (2025-2030)
12.1.2 Global Hereditary Angioedema Treatment Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hereditary Angioedema Treatment Forecast by Type
12.7 Global Hereditary Angioedema Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Hereditary Angioedema Treatment Product Portfolios and Specifications
13.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 Pharming Group
13.2.1 Pharming Group Company Information
13.2.2 Pharming Group Hereditary Angioedema Treatment Product Portfolios and Specifications
13.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pharming Group Main Business Overview
13.2.5 Pharming Group Latest Developments
13.3 Shire plc (Takeda Pharmaceutical Company Limited)
13.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Company Information
13.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Portfolios and Specifications
13.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Main Business Overview
13.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Latest Developments
13.4 Ionis Pharmaceuticals
13.4.1 Ionis Pharmaceuticals Company Information
13.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ionis Pharmaceuticals Main Business Overview
13.4.5 Ionis Pharmaceuticals Latest Developments
13.5 Attune Pharmaceuticals
13.5.1 Attune Pharmaceuticals Company Information
13.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Attune Pharmaceuticals Main Business Overview
13.5.5 Attune Pharmaceuticals Latest Developments
13.6 BioCryst Pharmaceuticals
13.6.1 BioCryst Pharmaceuticals Company Information
13.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BioCryst Pharmaceuticals Main Business Overview
13.6.5 BioCryst Pharmaceuticals Latest Developments
13.7 KalVista Pharmaceuticals
13.7.1 KalVista Pharmaceuticals Company Information
13.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
13.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 KalVista Pharmaceuticals Main Business Overview
13.7.5 KalVista Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hereditary Angioedema Treatment Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Hereditary Angioedema Treatment Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Table 4. Major Players of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Table 5. Major Players of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Table 6. Major Players of Others (Conventional Drugs, Pipeline Drugs)
Table 7. Global Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 8. Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Table 9. Global Hereditary Angioedema Treatment Revenue by Type (2019-2024) & ($ million)
Table 10. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2019-2024)
Table 11. Global Hereditary Angioedema Treatment Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 13. Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Table 14. Global Hereditary Angioedema Treatment Revenue by Application (2019-2024)
Table 15. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2019-2024)
Table 16. Global Hereditary Angioedema Treatment Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Hereditary Angioedema Treatment Sales by Company (2019-2024) & (K Units)
Table 18. Global Hereditary Angioedema Treatment Sales Market Share by Company (2019-2024)
Table 19. Global Hereditary Angioedema Treatment Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Hereditary Angioedema Treatment Revenue Market Share by Company (2019-2024)
Table 21. Global Hereditary Angioedema Treatment Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Hereditary Angioedema Treatment Producing Area Distribution and Sales Area
Table 23. Players Hereditary Angioedema Treatment Products Offered
Table 24. Hereditary Angioedema Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Hereditary Angioedema Treatment Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Hereditary Angioedema Treatment Sales Market Share Geographic Region (2019-2024)
Table 29. Global Hereditary Angioedema Treatment Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Hereditary Angioedema Treatment Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Hereditary Angioedema Treatment Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Hereditary Angioedema Treatment Sales Market Share by Country/Region (2019-2024)
Table 33. Global Hereditary Angioedema Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Hereditary Angioedema Treatment Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Hereditary Angioedema Treatment Sales by Country (2019-2024) & (K Units)
Table 36. Americas Hereditary Angioedema Treatment Sales Market Share by Country (2019-2024)
Table 37. Americas Hereditary Angioedema Treatment Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Hereditary Angioedema Treatment Revenue Market Share by Country (2019-2024)
Table 39. Americas Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 40. Americas Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 41. APAC Hereditary Angioedema Treatment Sales by Region (2019-2024) & (K Units)
Table 42. APAC Hereditary Angioedema Treatment Sales Market Share by Region (2019-2024)
Table 43. APAC Hereditary Angioedema Treatment Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Hereditary Angioedema Treatment Revenue Market Share by Region (2019-2024)
Table 45. APAC Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 46. APAC Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 47. Europe Hereditary Angioedema Treatment Sales by Country (2019-2024) & (K Units)
Table 48. Europe Hereditary Angioedema Treatment Sales Market Share by Country (2019-2024)
Table 49. Europe Hereditary Angioedema Treatment Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Hereditary Angioedema Treatment Revenue Market Share by Country (2019-2024)
Table 51. Europe Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 52. Europe Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Hereditary Angioedema Treatment Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Hereditary Angioedema Treatment Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Hereditary Angioedema Treatment Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Hereditary Angioedema Treatment
Table 60. Key Market Challenges & Risks of Hereditary Angioedema Treatment
Table 61. Key Industry Trends of Hereditary Angioedema Treatment
Table 62. Hereditary Angioedema Treatment Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Hereditary Angioedema Treatment Distributors List
Table 65. Hereditary Angioedema Treatment Customer List
Table 66. Global Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Hereditary Angioedema Treatment Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Hereditary Angioedema Treatment Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Hereditary Angioedema Treatment Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Hereditary Angioedema Treatment Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Hereditary Angioedema Treatment Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Hereditary Angioedema Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Hereditary Angioedema Treatment Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Hereditary Angioedema Treatment Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Hereditary Angioedema Treatment Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. CSL Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 81. CSL Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 82. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. CSL Main Business
Table 84. CSL Latest Developments
Table 85. Pharming Group Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 86. Pharming Group Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 87. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pharming Group Main Business
Table 89. Pharming Group Latest Developments
Table 90. Shire plc (Takeda Pharmaceutical Company Limited) Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 91. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 92. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Shire plc (Takeda Pharmaceutical Company Limited) Main Business
Table 94. Shire plc (Takeda Pharmaceutical Company Limited) Latest Developments
Table 95. Ionis Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 97. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Ionis Pharmaceuticals Main Business
Table 99. Ionis Pharmaceuticals Latest Developments
Table 100. Attune Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 102. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Attune Pharmaceuticals Main Business
Table 104. Attune Pharmaceuticals Latest Developments
Table 105. BioCryst Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 107. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. BioCryst Pharmaceuticals Main Business
Table 109. BioCryst Pharmaceuticals Latest Developments
Table 110. KalVista Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 112. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. KalVista Pharmaceuticals Main Business
Table 114. KalVista Pharmaceuticals Latest Developments
Table 1. Hereditary Angioedema Treatment Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Hereditary Angioedema Treatment Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Table 4. Major Players of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Table 5. Major Players of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Table 6. Major Players of Others (Conventional Drugs, Pipeline Drugs)
Table 7. Global Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 8. Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Table 9. Global Hereditary Angioedema Treatment Revenue by Type (2019-2024) & ($ million)
Table 10. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2019-2024)
Table 11. Global Hereditary Angioedema Treatment Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 13. Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Table 14. Global Hereditary Angioedema Treatment Revenue by Application (2019-2024)
Table 15. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2019-2024)
Table 16. Global Hereditary Angioedema Treatment Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Hereditary Angioedema Treatment Sales by Company (2019-2024) & (K Units)
Table 18. Global Hereditary Angioedema Treatment Sales Market Share by Company (2019-2024)
Table 19. Global Hereditary Angioedema Treatment Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Hereditary Angioedema Treatment Revenue Market Share by Company (2019-2024)
Table 21. Global Hereditary Angioedema Treatment Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Hereditary Angioedema Treatment Producing Area Distribution and Sales Area
Table 23. Players Hereditary Angioedema Treatment Products Offered
Table 24. Hereditary Angioedema Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Hereditary Angioedema Treatment Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Hereditary Angioedema Treatment Sales Market Share Geographic Region (2019-2024)
Table 29. Global Hereditary Angioedema Treatment Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Hereditary Angioedema Treatment Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Hereditary Angioedema Treatment Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Hereditary Angioedema Treatment Sales Market Share by Country/Region (2019-2024)
Table 33. Global Hereditary Angioedema Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Hereditary Angioedema Treatment Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Hereditary Angioedema Treatment Sales by Country (2019-2024) & (K Units)
Table 36. Americas Hereditary Angioedema Treatment Sales Market Share by Country (2019-2024)
Table 37. Americas Hereditary Angioedema Treatment Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Hereditary Angioedema Treatment Revenue Market Share by Country (2019-2024)
Table 39. Americas Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 40. Americas Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 41. APAC Hereditary Angioedema Treatment Sales by Region (2019-2024) & (K Units)
Table 42. APAC Hereditary Angioedema Treatment Sales Market Share by Region (2019-2024)
Table 43. APAC Hereditary Angioedema Treatment Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Hereditary Angioedema Treatment Revenue Market Share by Region (2019-2024)
Table 45. APAC Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 46. APAC Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 47. Europe Hereditary Angioedema Treatment Sales by Country (2019-2024) & (K Units)
Table 48. Europe Hereditary Angioedema Treatment Sales Market Share by Country (2019-2024)
Table 49. Europe Hereditary Angioedema Treatment Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Hereditary Angioedema Treatment Revenue Market Share by Country (2019-2024)
Table 51. Europe Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 52. Europe Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Hereditary Angioedema Treatment Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Hereditary Angioedema Treatment Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Hereditary Angioedema Treatment Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Hereditary Angioedema Treatment Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Hereditary Angioedema Treatment Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Hereditary Angioedema Treatment
Table 60. Key Market Challenges & Risks of Hereditary Angioedema Treatment
Table 61. Key Industry Trends of Hereditary Angioedema Treatment
Table 62. Hereditary Angioedema Treatment Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Hereditary Angioedema Treatment Distributors List
Table 65. Hereditary Angioedema Treatment Customer List
Table 66. Global Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Hereditary Angioedema Treatment Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Hereditary Angioedema Treatment Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Hereditary Angioedema Treatment Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Hereditary Angioedema Treatment Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Hereditary Angioedema Treatment Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Hereditary Angioedema Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Hereditary Angioedema Treatment Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Hereditary Angioedema Treatment Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Hereditary Angioedema Treatment Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. CSL Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 81. CSL Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 82. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. CSL Main Business
Table 84. CSL Latest Developments
Table 85. Pharming Group Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 86. Pharming Group Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 87. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pharming Group Main Business
Table 89. Pharming Group Latest Developments
Table 90. Shire plc (Takeda Pharmaceutical Company Limited) Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 91. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 92. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Shire plc (Takeda Pharmaceutical Company Limited) Main Business
Table 94. Shire plc (Takeda Pharmaceutical Company Limited) Latest Developments
Table 95. Ionis Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 97. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Ionis Pharmaceuticals Main Business
Table 99. Ionis Pharmaceuticals Latest Developments
Table 100. Attune Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 102. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Attune Pharmaceuticals Main Business
Table 104. Attune Pharmaceuticals Latest Developments
Table 105. BioCryst Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 107. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. BioCryst Pharmaceuticals Main Business
Table 109. BioCryst Pharmaceuticals Latest Developments
Table 110. KalVista Pharmaceuticals Basic Information, Hereditary Angioedema Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Portfolios and Specifications
Table 112. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. KalVista Pharmaceuticals Main Business
Table 114. KalVista Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hereditary Angioedema Treatment
Figure 2. Hereditary Angioedema Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hereditary Angioedema Treatment Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Hereditary Angioedema Treatment Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Hereditary Angioedema Treatment Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Figure 10. Product Picture of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Figure 11. Product Picture of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Figure 12. Product Picture of Others (Conventional Drugs, Pipeline Drugs)
Figure 13. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2023
Figure 14. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2019-2024)
Figure 15. Hereditary Angioedema Treatment Consumed in Hospital Pharmacies
Figure 16. Global Hereditary Angioedema Treatment Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 17. Hereditary Angioedema Treatment Consumed in Retail Pharmacies
Figure 18. Global Hereditary Angioedema Treatment Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 19. Hereditary Angioedema Treatment Consumed in Others (online pharmacies, mail pharmacies)
Figure 20. Global Hereditary Angioedema Treatment Market: Others (online pharmacies, mail pharmacies) (2019-2024) & (K Units)
Figure 21. Global Hereditary Angioedema Treatment Sales Market Share by Application (2023)
Figure 22. Global Hereditary Angioedema Treatment Revenue Market Share by Application in 2023
Figure 23. Hereditary Angioedema Treatment Sales Market by Company in 2023 (K Units)
Figure 24. Global Hereditary Angioedema Treatment Sales Market Share by Company in 2023
Figure 25. Hereditary Angioedema Treatment Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Hereditary Angioedema Treatment Revenue Market Share by Company in 2023
Figure 27. Global Hereditary Angioedema Treatment Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Hereditary Angioedema Treatment Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 30. Americas Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 31. APAC Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 32. APAC Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 33. Europe Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 34. Europe Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 37. Americas Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 38. Americas Hereditary Angioedema Treatment Revenue Market Share by Country in 2023
Figure 39. Americas Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 40. Americas Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 41. United States Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Hereditary Angioedema Treatment Sales Market Share by Region in 2023
Figure 46. APAC Hereditary Angioedema Treatment Revenue Market Share by Regions in 2023
Figure 47. APAC Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 48. APAC Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 49. China Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 57. Europe Hereditary Angioedema Treatment Revenue Market Share by Country in 2023
Figure 58. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 59. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 60. Germany Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Hereditary Angioedema Treatment Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 69. Egypt Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Hereditary Angioedema Treatment in 2023
Figure 75. Manufacturing Process Analysis of Hereditary Angioedema Treatment
Figure 76. Industry Chain Structure of Hereditary Angioedema Treatment
Figure 77. Channels of Distribution
Figure 78. Global Hereditary Angioedema Treatment Sales Market Forecast by Region (2025-2030)
Figure 79. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Hereditary Angioedema Treatment
Figure 2. Hereditary Angioedema Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hereditary Angioedema Treatment Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Hereditary Angioedema Treatment Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Hereditary Angioedema Treatment Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Figure 10. Product Picture of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Figure 11. Product Picture of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Figure 12. Product Picture of Others (Conventional Drugs, Pipeline Drugs)
Figure 13. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2023
Figure 14. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2019-2024)
Figure 15. Hereditary Angioedema Treatment Consumed in Hospital Pharmacies
Figure 16. Global Hereditary Angioedema Treatment Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 17. Hereditary Angioedema Treatment Consumed in Retail Pharmacies
Figure 18. Global Hereditary Angioedema Treatment Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 19. Hereditary Angioedema Treatment Consumed in Others (online pharmacies, mail pharmacies)
Figure 20. Global Hereditary Angioedema Treatment Market: Others (online pharmacies, mail pharmacies) (2019-2024) & (K Units)
Figure 21. Global Hereditary Angioedema Treatment Sales Market Share by Application (2023)
Figure 22. Global Hereditary Angioedema Treatment Revenue Market Share by Application in 2023
Figure 23. Hereditary Angioedema Treatment Sales Market by Company in 2023 (K Units)
Figure 24. Global Hereditary Angioedema Treatment Sales Market Share by Company in 2023
Figure 25. Hereditary Angioedema Treatment Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Hereditary Angioedema Treatment Revenue Market Share by Company in 2023
Figure 27. Global Hereditary Angioedema Treatment Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Hereditary Angioedema Treatment Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 30. Americas Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 31. APAC Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 32. APAC Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 33. Europe Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 34. Europe Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Hereditary Angioedema Treatment Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Hereditary Angioedema Treatment Revenue 2019-2024 ($ Millions)
Figure 37. Americas Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 38. Americas Hereditary Angioedema Treatment Revenue Market Share by Country in 2023
Figure 39. Americas Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 40. Americas Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 41. United States Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Hereditary Angioedema Treatment Sales Market Share by Region in 2023
Figure 46. APAC Hereditary Angioedema Treatment Revenue Market Share by Regions in 2023
Figure 47. APAC Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 48. APAC Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 49. China Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 57. Europe Hereditary Angioedema Treatment Revenue Market Share by Country in 2023
Figure 58. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 59. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 60. Germany Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Hereditary Angioedema Treatment Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 69. Egypt Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Hereditary Angioedema Treatment Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Hereditary Angioedema Treatment in 2023
Figure 75. Manufacturing Process Analysis of Hereditary Angioedema Treatment
Figure 76. Industry Chain Structure of Hereditary Angioedema Treatment
Figure 77. Channels of Distribution
Figure 78. Global Hereditary Angioedema Treatment Sales Market Forecast by Region (2025-2030)
Figure 79. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Application (2025-2030)
